AAAAAA
Results: 1-25/30
Authors:
Chintalacharuvu, KR
Vuong, LUC
Loi, LA
Larrick, JW
Morrison, SL
Citation: Kr. Chintalacharuvu et al., Hybrid IgA2/IgG1 antibodies with tailor-made effector functions, CLIN IMMUNO, 101(1), 2001, pp. 21-31
Authors:
Peng, LS
Penichet, ML
Dela Cruz, JS
Sampogna, SL
Morrison, SL
Citation: Ls. Peng et al., Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3), J INTERF CY, 21(9), 2001, pp. 709-720
Authors:
Morrison, SL
Citation: Sl. Morrison, Robert Cruickshank (Jim) Burgess - Obituary, BR MED J, 322(7287), 2001, pp. 678-678
Authors:
Penichet, ML
Dela Cruz, JS
Challita-Eid, PM
Rosenblatt, JD
Morrison, SL
Citation: Ml. Penichet et al., A murine B cell lymphoma expressing human HER2/neu undergoes spontaneous tumor regression and elicits antitumor immunity, CANCER IMMU, 49(12), 2001, pp. 649-662
Authors:
Chan, LA
Lyczak, JB
Zhang, K
Morrison, SL
Saxon, A
Citation: La. Chan et al., The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex (vol 37, pg 241, 2000), MOL IMMUNOL, 38(5), 2001, pp. 409-409
Authors:
Penichet, ML
Morrison, SL
Citation: Ml. Penichet et Sl. Morrison, Antibody-cytokine fusion proteins for the therapy of cancer, J IMMUNOL M, 248(1-2), 2001, pp. 91-101
Authors:
Zhang, HF
Lu, SL
Morrison, SL
Tomlinson, S
Citation: Hf. Zhang et al., Targeting the functional antibody-decay-accelerating factor fusion proteins to a cell surface, J BIOL CHEM, 276(29), 2001, pp. 27290-27295
Authors:
Wright, A
Sato, Y
Okada, T
Chang, KH
Endo, T
Morrison, SL
Citation: A. Wright et al., In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure, GLYCOBIOLOG, 10(12), 2000, pp. 1347-1355
Authors:
Morrison, SL
Obrand, DA
Steinmetz, OK
Montreuil, B
Citation: Sl. Morrison et al., Treatment of femoral artery pseudoaneurysms with percutaneous thrombin injection, ANN VASC S, 14(6), 2000, pp. 634-639
Authors:
Coloma, MJ
Lee, HJ
Kurihara, A
Landaw, EM
Boado, RJ
Morrison, SL
Pardridge, WM
Citation: Mj. Coloma et al., Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor, PHARM RES, 17(3), 2000, pp. 266-274
Authors:
Mateo, C
Lombardero, J
Moreno, E
Morales, A
Bombino, G
Coloma, J
Wims, L
Morrison, SL
Perez, R
Citation: C. Mateo et al., Removal of amphipathic epitopes from genetically engineered antibodies: Production of modified immunoglobulins with reduced immunogenicity, HYBRIDOMA, 19(6), 2000, pp. 463-471
Authors:
Chan, LA
Lyczak, JB
Zhang, K
Morrison, SL
Saxon, A
Citation: La. Chan et al., The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex, MOL IMMUNOL, 37(5), 2000, pp. 241-252
Authors:
Coloma, MJ
Clift, A
Wims, L
Morrison, SL
Citation: Mj. Coloma et al., The role of carbohydrate in the assembly and function of polymeric IgG, MOL IMMUNOL, 37(18), 2000, pp. 1081-1090
Authors:
Chan, LA
Lyczak, JB
Zhang, K
Morrison, SL
Saxon, A
Citation: La. Chan et al., The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex (vol 37, pg 241, 2000), MOL IMMUNOL, 37(18), 2000, pp. 1151-1151
Authors:
Dela Cruz, JS
Trinh, KR
Morrison, SL
Penichet, ML
Citation: Js. Dela Cruz et al., Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity, J IMMUNOL, 165(9), 2000, pp. 5112-5121
Authors:
Trinh, KR
Morrison, SL
Citation: Kr. Trinh et Sl. Morrison, Site-specific and directional gene replacement mediated by Cre recombinase, J IMMUNOL M, 244(1-2), 2000, pp. 185-193
Authors:
Rifai, A
Fadden, K
Morrison, SL
Chintalacharuvu, KR
Citation: A. Rifai et al., The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes, J EXP MED, 191(12), 2000, pp. 2171-2181
Authors:
Morrison, SL
Campbell, CK
Wright, GM
Citation: Sl. Morrison et al., Chondrogenesis of the branchial skeleton in embryonic sea lamprey, Petromyzon marinus, ANAT REC, 260(3), 2000, pp. 252-267
Authors:
Bonagura, VR
Kwong, T
Kenny, T
Robbins, DL
Morrison, SL
Citation: Vr. Bonagura et al., The specificity of synovial IgM rheumatoid factors (RF) for genetically engineered IgG antibodies is not affected by the method used to immortalize RF-producing B cells, SC J IMMUN, 49(1), 1999, pp. 106-111
Authors:
Penichet, ML
Challita, PM
Shin, SU
Sampogna, SL
Rosenblatt, JD
Morrison, SL
Citation: Ml. Penichet et al., In vivo properties of three human HER2/neu-expressing murine cell lines inimmunocompetent mice, LAB ANIM SC, 49(2), 1999, pp. 179-188
Authors:
Penichet, ML
Kang, YS
Pardridge, WM
Morrison, SL
Shin, SU
Citation: Ml. Penichet et al., An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: Initial applications in anti-HIV antisense drug delivery to the brain, J IMMUNOL, 163(8), 1999, pp. 4421-4426
Authors:
Peng, LS
Penichet, ML
Morrison, SL
Citation: Ls. Peng et al., A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity, J IMMUNOL, 163(1), 1999, pp. 250-258
Authors:
Coloma, MJ
Trinh, RK
Martinez, AR
Morrison, SL
Citation: Mj. Coloma et al., Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1 -> 6) dextran antibody, J IMMUNOL, 162(4), 1999, pp. 2162-2170
A colorimetric-enzymatic microassay for the quantitation of antibody-dependent complement activation
Authors:
Montano, RF
Morrison, SL
Citation: Rf. Montano et Sl. Morrison, A colorimetric-enzymatic microassay for the quantitation of antibody-dependent complement activation, J IMMUNOL M, 222(1-2), 1999, pp. 73-82
Authors:
Zhang, HF
Yu, JH
Bajwa, E
Morrison, SL
Tomlinson, S
Citation: Hf. Zhang et al., Targeting of functional antibody-CD59 fusion proteins to a cell surface, J CLIN INV, 103(1), 1999, pp. 55-61